Jm Clinical Research Managemen is categorized under Management Services in Raleigh, NC and active since 2007.
Jm Clinical Research Managemen was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Management Services business, which does work in the B2B market, and is classified as a Management Services, under code number 561110 by the NAICS.
If you are seeking more information, feel free to contact Mabellos J Herrera at the company’s single location by writing to 11409 Creedmoor Road, Raleigh, North Carolina NC 27614 or by phoning (919) 332-9730. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jm Clinical Research Managemen |
| Contact Person: | Mabellos J Herrera |
| Address: | 11409 Creedmoor Road, Raleigh, North Carolina 27614 |
| Phone Number: | (919) 332-9730 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Management Services |
| SIC Code: | 8741 |
| NAICS Code: | 561110 |
| Share This Business: |
Jm Clinical Research Managemen was started in 2007 to provide professional Management Services under the SIC code 8741 and NAICS code 561110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Mabellos J Herrera for inquiries that concern Jm Clinical Research Managemen by calling the company number (919) 332-9730, as your correspondence is most welcome. Additionally, the physical location of the single location of Jm Clinical Research Managemen can be found at the coordinates 35.954322,-78.687422 as well as the street address 11409 Creedmoor Road in Raleigh, North Carolina 27614.
For its online presence, you may visit Jm Clinical Research Managemen’s website at and engage with its social media outlets through on Twitter and on Facebook.